MSRA-2790

An 80-year-old man with terminal lung cancer is evaluated by the palliative care team to determine his analgesic requirements. He is currently on a regimen of 30 mg slow-release morphine twice daily, which effectively manages his pain. However, he is experiencing difficulty swallowing both tablet and liquid forms of the medication. The palliative team suggests transitioning him to subcutaneous morphine. What is the appropriate daily dosage for him?